ClinicalTrials.gg
RecruitingNCT04772183OxyGapUpdated Jun 18, 2024

OxyGap : Comparison Between Different Pulse Oximeter and With the Arterial Blood Gase

An observational study in Respiratory Failure, Hypoxemia and Hyperoxemia, sponsored by Laval University. Recruiting at 2 sites in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-18.

Sponsored by Laval University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Mar 2021; still recruiting 5 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 94 studies in Respiratory Insufficiency with a site in Canada — 24 open to participants now, 29 under way, 1 of them phase 3. Respiratory Insufficiency · Canada.

Planned enrollment
4th of 28
300 · median 118
Started
2021
with 5 others
Observational
28 of 94
9 open now
Primary completion
2024-12
later than 3 of 28 live
Registered
65th of 94
by date
Lead sponsor
8 of 94
Laval University

Among the 94 studies in Respiratory Insufficiency with a site in Canada, this one is the 4th largest by planned enrollment of the 28 observational ones that give a count, is one of 6 that started in 2021, is one of 28 observational ones, reaches primary completion later than 3 of the 28 other live ones, and was the 65th registered.

Respiratory Insufficiency

1,371 studies on the registry are indexed under Respiratory Insufficiency; 266 are open to participants now.

Browse Respiratory Insufficiency studies →

Open to participants now

24 of the 94 studies in Respiratory Insufficiency with a site in Canada are open now. Recruiting first, the newest first:

18 more — sign in →

All 24 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 180 Respiratory Insufficiency studies recruiting now, 135 (75%) set no upper age limit and 18 (10%) stop at 75 or younger; 21 take children under 18; 20 take healthy volunteers.

This study: 18 Years and older · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 94 studies in Respiratory Insufficiency with a site in Canada, or all of them as a file.
02

Study summary

The oximeter is used to monitor intensive care patients undergoing oxygen therapy. It indicates pulsed oxygen saturation (SpO2), a reflection of arterial oxygen saturation (SaO2) which enables detection of hypoxemia and hyperoxia, both deleterious state. Current SpO2 recommendations aim to reduce both risk of hypoxemia and hyperoxia. SpO2 is considered the 5th vital sign.

Current recommendations for SpO2 targets do not consider the variability of oximeters used in clinical practice. This variability and lack of specification represent an obstacle to an optimal practice of oxygen therapy.

Thus, this study aims to compare the SpO2 values of different oximeters (Nonin, Masimo, Philips, Nellcor) used in clinical practice with the SaO2 reference value obtained by an arterial gas in order to specify the precision and the systematic biases of the oximeters studied. This data will also make it possible to refine the recommendations concerning optimal oxygenation

03

Conditions studied

  • Respiratory Failure
  • Hypoxemia
  • Hyperoxemia
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

All patient in ICU with arterial catheter already installed will be consider.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥ 18 years old
  • Patients admitted to the Intensive Care Unit
  • Artery catheter already installed

Exclusion criteria

Exclusion Criteria:

  • No signal with the oximeter
  • Pigmented nails or nail polish
  • Methemoglobinemia
  • Patient in isolation (multi-resistant bacteria, C-Difficile, COVID-19...)
  • Prone position
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No

Interventions

  • DeviceSpO2 and SaO2 comparison

    Several pulse oximeter will be place on patient find few minutes before arterial blood gases. During an arterial blood sample, all SpO2 will be recorded

06

What researchers measure

Primary outcomes

  1. Diffence between Nellcor SpO2 and the SaO2 value

    Diffence between Nellcor oximeter SpO2 and the SaO2 value

    Time frame: During arterial blood gase sample

  2. Diffence between FreeO2 SpO2 and the SaO2 value

    Diffence between Nonin (FreeO2) oximeter SpO2 and the SaO2 value

    Time frame: During arterial blood gase sample

  3. Diffence between Nonin ear clip and the SaO2 value

    Diffence between Nonin (ear sensor) oximeter SpO2 and the SaO2 value

    Time frame: During arterial blood gase sample

  4. Diffence between Masimo SpO2 and the SaO2 value

    Diffence between Masimo oximeter SpO2 and the SaO2 value

    Time frame: During arterial blood gase sample

  5. Diffence between Philips SpO2 and the SaO2 value

    Diffence between Philips oximeter SpO2 and the SaO2 value

    Time frame: During arterial blood gase sample

  6. Diffence between Contec SpO2 and the SaO2 value

    Difffence between Contec oximeter SpO2 and the SaO2 value

    Time frame: During arterial blood gase sample

  7. Diffence between Bejing choice SpO2 and the SaO2 value

    Diffence between Bejing choice oximeter SpO2 and the SaO2 value

    Time frame: During arterial blood gase sample

Secondary outcomes

  1. Overestimation and underestimation of SaO2

    % of pairs with overestimation and underestimation of SaO2 for each oximeter.

    Time frame: During arterial blood gase sample

  2. Hypoxemia detection

    Ability to detect hypoxemia (SpO2 below 90% and PaO2 \< 60 mmHg)

    Time frame: During arterial blood gase sample

  3. Hyperoxemia detection

    Ability to detect hyperoxemia (SpO2 above 95% and PaO2 \> 100 mmHg)

    Time frame: During arterial blood gase sample

  4. Gaps between the different oximeters

    Average of the SpO2 value gaps between the different oximeters tested

    Time frame: During arterial blood gase sample

  5. Finger and ear sensor comparison

    Comparison of the finger sensor and ear clip sensor for Nonin oximeter

    Time frame: During arterial blood gase sample

07

Study locations

1 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2021 (actual). Primary completion is estimated for Dec 2024, 45 months after the start.

Of 232 non-industry observational studies under Respiratory Insufficiency, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 54. This study's planned 45 months is above that.

Counting every sponsor, half of 248 studies reached it within 22 months; a quarter within 12 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 17, 2021
First posted
Feb 26, 2021
StartActual
Mar 24, 2021
Primary completionEst.
Dec 31, 2024
CompletionEst.
Jun 30, 2025
Last update
Jun 18, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04772183
Lead sponsor
Laval University
Responsible party
François Lellouche (Principal investigator, Laval University) — Principal investigator
First posted
Feb 26, 2021
Start date
Mar 24, 2021
Primary completion
Dec 31, 2024 (estimated)
Completion
Jun 30, 2025 (estimated)
Last update
Jun 18, 2024

Study contacts

François Lellouche
Contact
francois.lellouche@criucpq.ulaval.ca
418-656-8711 ext. 3572
Pierre-alexandre Bouchard
Contact
pierre-alexandre.bouchard@criucpq.ulaval.ca
418-656-8711 ext. 2712

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion